Pellegrino Rachael A, Rebeiro Peter F, Turner Megan, Davidson Amber, Best Noelle, Shaffernocker Chandler, Kheshti Asghar, Kelly Sean, Raffanti Stephen, Sterling Timothy R, Castilho Jessica L
Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Open Forum Infect Dis. 2022 Dec 19;10(1):ofac678. doi: 10.1093/ofid/ofac678. eCollection 2023 Jan.
Since the availability of antiretroviral therapy, mortality rates among people with HIV (PWH) have decreased; however, this does not quantify premature deaths among PWH, and disparities persist.
We examined all-cause and premature mortality among PWH receiving care at the Vanderbilt Comprehensive Care Clinic from January 1998 to December 2018. Mortality rates were compared by demographic and clinical factors, and adjusted incidence rate ratios (aIRRs) were calculated using multivariable Poisson regression. For individuals who died, age-adjusted years of potential life lost (aYPLL) per total person-years living with HIV were calculated from US sex-specific life tables, and sex and race differences were examined using multivariable linear regression.
Among 6531 individuals (51% non-Hispanic [NH] White race, 40% NH Black race, 21% cis-gender women, 78% cis-gender men) included, 956 (14.6%) died. In adjusted analysis, PWH alive in the most recent calendar era (2014-2018) had decreased risk of mortality compared with those in the earliest calendar era (1998-2003; aIRR, 0.22; 95% CI, 0.17-0.29), and women had increased risk of death compared with men (aIRR, 1.31; 95% CI, 1.12-1.54). Of those who died, Black women had the highest aYPLL (aIRR, 592.5; 95% CI, 588.4-596.6), followed by Black men (aIRR, 470.7; 95% CI, 468.4-472.9), White women (aIRR, 411.5; 95% CI, 405.6-417.4), then White men (aIRR, 308.6; 95% CI, 308.0-309.2). In adjusted models, higher YPLL remained associated with NH Black race and cis-gender women, regardless of HIV risk factor.
Despite marked improvement over time, sex disparities in mortality as well as sex and race disparities in YPLL remained among PWH in this cohort.
自抗逆转录病毒疗法问世以来,艾滋病毒感染者(PWH)的死亡率有所下降;然而,这并未量化PWH中的过早死亡情况,且差异依然存在。
我们调查了1998年1月至2018年12月在范德比尔特综合护理诊所接受治疗的PWH的全因死亡率和过早死亡率。按人口统计学和临床因素比较死亡率,并使用多变量泊松回归计算调整后的发病率比(aIRR)。对于死亡的个体,根据美国特定性别的生命表计算每艾滋病毒感染者总人年的年龄调整潜在寿命损失(aYPLL),并使用多变量线性回归检查性别和种族差异。
纳入的6531名个体中(51%为非西班牙裔[NH]白人,40%为NH黑人,21%为顺性别女性,78%为顺性别男性),956人(14.6%)死亡。在调整分析中,与最早日历时期(1998 - 2003年)的PWH相比,最近日历时期(2014 - 2018年)存活的PWH死亡风险降低(aIRR,0.22;95%置信区间,0.17 - 0.29),且女性死亡风险高于男性(aIRR,1.31;95%置信区间,1.12 - 1.54)。在死亡者中,黑人女性的aYPLL最高(aIRR,592.5;95%置信区间,588.4 - 596.6),其次是黑人男性(aIRR,470.7;95%置信区间,468.4 - 472.9)、白人女性(aIRR,411.5;95%置信区间,405.6 - 417.4),然后是白人男性(aIRR,308.6;95%置信区间,308.0 - 309.2)。在调整模型中,无论艾滋病毒风险因素如何,较高的YPLL仍与NH黑人种族和顺性别女性相关。
尽管随着时间推移有显著改善,但该队列中PWH的死亡率性别差异以及YPLL的性别和种族差异依然存在。